Level Brands Inc. entered into a License Agreement with Isodiol International Inc. Under the terms of the License Agreement Level Brands Inc. granted Isodiol International a non-exclusive, non-transferrable license to use the kathy ireland Health & Wellness™ in the marketing, development, manufacture, sale and distribution of cannabidiol (CBD) related products in the United States and Canada. The initial term of the License Agreement is five years, with automatic two year extensions unless either party notifies the other of non-renewal at least 90 days prior to the end of the then current term. As compensation, Level Brands will receive a licensing fee of $125,000, with $62,500 paid upon the execution of the License Agreement and the balance due by June 30, 2018, 1,679,321 shares of Isodiol International's common stock, which is equal to $2 million, upon the execution of the License Agreement, additional shares of Isodiol International's common stock on the last day of each calendar quarter commencing March 31, 2018 in such amount as shall equal $750,000 based upon the closing price of such shares on the last business day of the quarter and a royalty of 3% of the gross licensed marks sales, payable monthly. The parties agreed to confer and mutually decide in good faith prior to January 31, 2018 whether to move forward with the transactions contemplated by the License Agreement. If the parties determine not to move forward, either party may terminate the agreement upon written notice in which event Level Brands Inc. will not receive any compensation.